This is a light week for research due to low market participation at firms. These are this Tuesday’s top analyst upgrades, downgrades and initiations seen from Wall Street research calls.
BB&T Corp. (NYSE: BBT) was downgraded to Hold from Buy at Rafferty Capital with a $41 price target (versus a $39.37 close).
Cnova N.V. (NYSE: CNV) was started as Overweight with an $11 price target (versus a $7.28 close) at J.P. Morgan.
Eagle Materials Inc. (NYSE: EXP) was reiterated as Buy and the price target was raised to $110 from $98 (versus $77.93 close) at Stifel Nicolaus.
Gulfport Energy Corp. (NASDAQ: GPOR) was started as Buy with a $58 price target (versus $41.98 close) at Topeka Capital Markets.
ALSO READ: The 5 Cheapest Dow Stocks for 2015
Hyperion Therapeutics Inc. (NASDAQ: HPTX) was started as Buy at Brean Capital.
Manitowoc Co. Inc. (NYSE: MTW) was reiterated as Outperform and with a $27 price target (versus a $22.79 close) at Credit Suisse.
Osiris Therapeutics Inc. (NASDAQ: OSIR) was started as Buy at Brean Capital.
Pernix Therapeutics Holdings Inc. (NASDAQ: PTX) was started as Market Outperform with a $13 price target (versus a $9.39 close) at JMP Securities.
Procter & Gamble Co. (NYSE: PG) was downgraded to Neutral from Buy at BTIG.
QLogic Corp. (NASDAQ: QLGC) was started as Buy with a $17 price target (versus a $12.77 close) at D.A. Davidson.
Virgin America Inc. (NASDAQ: VA) was reiterated as Outperform and the price target was raised to $53 from $42 (versus a $42.53 close) at Cowen.
In case you missed Monday’s top analyst calls, they included Ambarella, Gilead Sciences, MarkWest Energy Partners, PNC Financial Services, Skyworks Solutions, RigNet, Sonus Networks and a half dozen or so more.
ALSO READ: The Best Performing Biotech Stocks of 2014: 300% Gains!
Top Gaining Stocks
Top Losing Stocks